Literature DB >> 11748408

Stereospecific effect of pregabalin on ectopic afferent discharges and neuropathic pain induced by sciatic nerve ligation in rats.

S R Chen1, Z Xu, H L Pan.   

Abstract

BACKGROUND: The new anticonvulsants, gabapentin and pregabalin, are effective in the treatment of neuropathic pain. The sites and mechanisms of their analgesic action are not fully known. The authors have previously demonstrated that systemic gabapentin suppresses ectopic afferent discharges recorded from injured sciatic nerves in rats. In the current study, they further examined the stereospecific effect of pregabalin on neuropathic pain and afferent ectopic discharges in a rodent model of neuropathic pain.
METHODS: Tactile allodynia and thermal hyperalgesia were induced by partial ligation of the left sciatic nerve in rats. Single-unit activity of afferent ectopic discharges was recorded from the sciatic nerve proximal to the site of ligation.
RESULTS: Intravenous injection of 10-30 mg/kg pregabalin dose-dependently attenuated tactile allodynia (n = 10) and thermal hyperalgesia (n = 8). The stereoisomer of pregabalin, R-3-isobutylgaba, had no analgesic effect in this dose range. Furthermore, intravenous injection of pregabalin, but not R-3-isobutylgaba, significantly inhibited the ectopic discharges from injured afferents in a dose-dependent manner (from 20.8 +/- 2.4 impulses/s during control to 2.3 +/- 0.7 impulses/s after treatment with 30 mg/kg pregabalin, n = 15). Pregabalin did not affect the conduction velocity of afferent fibers and the response of normal afferent nerves to mechanical stimulation.
CONCLUSIONS: These data strongly suggest that the analgesic effect of pregabalin on neuropathic pain is likely mediated, at least in part, by its peripheral inhibitory action on the impulse generation of ectopic discharges caused by nerve injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11748408     DOI: 10.1097/00000542-200112000-00029

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  17 in total

Review 1.  Pregabalin: in the treatment of postherpetic neuralgia.

Authors:  James E Frampton; Rachel H Foster
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Pregabalin abuse and dependence in Germany: results from a database query.

Authors:  Maximilian Gahr; Roland W Freudenmann; Christoph Hiemke; Makus A Kölle; Carlos Schönfeldt-Lecuona
Journal:  Eur J Clin Pharmacol       Date:  2013-01-05       Impact factor: 2.953

3.  Systemic pregabalin attenuates sensorimotor responses and medullary glutamate release in inflammatory tooth pain model.

Authors:  N Narita; N Kumar; P S Cherkas; C Y Chiang; J O Dostrovsky; T J Coderre; B J Sessle
Journal:  Neuroscience       Date:  2012-05-17       Impact factor: 3.590

4.  Pharmacokinetic/Pharmacodynamic Relationship of Gabapentin in a CFA-induced Inflammatory Hyperalgesia Rat Model.

Authors:  Malte Selch Larsen; Ron Keizer; Gordon Munro; Arne Mørk; René Holm; Rada Savic; Mads Kreilgaard
Journal:  Pharm Res       Date:  2016-01-15       Impact factor: 4.200

Review 5.  Pregabalin: in the treatment of painful diabetic peripheral neuropathy.

Authors:  James E Frampton; Lesley J Scott
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate.

Authors:  Naresh Kumar; Andre Laferriere; Jonathan S C Yu; Amelia Leavitt; Terence J Coderre
Journal:  J Neurochem       Date:  2010-01-28       Impact factor: 5.372

7.  Antiallodynic effect of pregabalin in rat models of sympathetically maintained and sympathetic independent neuropathic pain.

Authors:  Dong Woo Han; Tae Dong Kweon; Jong Seok Lee; Youn-Woo Lee
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759

8.  Pharmacologic management of chronic pain.

Authors:  Hue Jung Park; Dong Eon Moon
Journal:  Korean J Pain       Date:  2010-05-31

Review 9.  Pregabalin: in the treatment of postherpetic neuralgia.

Authors:  Kate McKeage; Susan J Keam
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

10.  Pregabalin suppresses nociceptive behavior and central sensitization in a rat trigeminal neuropathic pain model.

Authors:  Ye Cao; Hua Wang; Chen-Yu Chiang; Jonathan O Dostrovsky; Barry J Sessle
Journal:  J Pain       Date:  2013-02       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.